\BOOKMARK [1][-]{section.1}{Introduction}{}% 1
\BOOKMARK [1][-]{section.2}{Methods}{}% 2
\BOOKMARK [2][-]{subsection.2.1}{Dataset}{section.2}% 3
\BOOKMARK [2][-]{subsection.2.2}{Variant\040Class\040Observation\040Probability}{section.2}% 4
\BOOKMARK [2][-]{subsection.2.3}{Integrating\040observed\040true\040positives\040and\040unobserved\040false\040negatives\040into\040a\040single,\040actionable\040conclusion}{section.2}% 5
\BOOKMARK [2][-]{subsection.2.4}{Validation\040of\040Autosomal\040Dominant\040Estimates\040Using\040NFKB1}{section.2}% 6
\BOOKMARK [2][-]{subsection.2.5}{Validation\040Study\040for\040Autosomal\040Recessive\040CF\040Using\040CFTR}{section.2}% 7
\BOOKMARK [2][-]{subsection.2.6}{Validation of SCID-specific Estimates Using PIDâ€“SCID Genes}{section.2}% 8
\BOOKMARK [2][-]{subsection.2.7}{Protein\040Network\040and\040Genetic\040Constraint\040Interpretation}{section.2}% 9
\BOOKMARK [2][-]{subsection.2.8}{Gene\040Set\040Enrichment\040Test}{section.2}% 10
\BOOKMARK [2][-]{subsection.2.9}{Deriving\040novel\040PID\040classifications\040by\040genetic\040PPI\040and\040clinical\040features}{section.2}% 11
\BOOKMARK [2][-]{subsection.2.10}{Probability\040of\040observing\040AlphaMissense\040pathogenicity}{section.2}% 12
\BOOKMARK [1][-]{section.3}{Results}{}% 13
\BOOKMARK [2][-]{subsection.3.1}{Observation\040probability\040across\040disease\040genes}{section.3}% 14
\BOOKMARK [2][-]{subsection.3.2}{Integrating\040observed\040true\040positives\040and\040unobserved\040false\040negatives\040into\040a\040single,\040actionable\040conclusion}{section.3}% 15
\BOOKMARK [2][-]{subsection.3.3}{Validation\040studies}{section.3}% 16
\BOOKMARK [2][-]{subsection.3.4}{Genetic\040constraint\040in\040high-impact\040protein\040networks}{section.3}% 17
\BOOKMARK [2][-]{subsection.3.5}{New\040insight\040from\040functional\040enrichment}{section.3}% 18
\BOOKMARK [2][-]{subsection.3.6}{Genome-wide\040gene\040distribution\040and\040locus-specific\040variant\040occurrence}{section.3}% 19
\BOOKMARK [2][-]{subsection.3.7}{Novel\040PID\040classifications\040derived\040from\040genetic\040PPI\040and\040clinical\040features}{section.3}% 20
\BOOKMARK [2][-]{subsection.3.8}{Novel\040PID\040classifications\040derived\040from\040genetic\040PPI\040and\040clinical\040features}{section.3}% 21
\BOOKMARK [2][-]{subsection.3.9}{Probability\040of\040observing\040AlphaMissense\040pathogenicity}{section.3}% 22
\BOOKMARK [1][-]{section.4}{Discussion}{}% 23
\BOOKMARK [1][-]{section.5}{Conclusion}{}% 24
\BOOKMARK [1][-]{section.6}{Supplemental}{}% 25
\BOOKMARK [2][-]{subsection.6.1}{Integrating\040observed\040true\040positives\040and\040unobserved\040false\040negatives\040into\040a\040single,\040actionable\040conclusion}{section.6}% 26
\BOOKMARK [2][-]{subsection.6.2}{Validation\040studies}{section.6}% 27
\BOOKMARK [2][-]{subsection.6.3}{Hierarchical\040Clustering\040of\040Enrichment\040Scores\040for\040Major\040Disease\040Categories}{section.6}% 28
\BOOKMARK [2][-]{subsection.6.4}{Interpretation\040of\040ClinVar\040Variant\040Observations}{section.6}% 29
\BOOKMARK [2][-]{subsection.6.5}{Novel\040PID\040classifications}{section.6}% 30
\BOOKMARK [2][-]{subsection.6.6}{Probability\040of\040observing\040AlphaMissense\040pathogenicity}{section.6}% 31
